Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiproliferative and quinone reductase-inducing activities of withanolides derivatives.
García ME, Nicotra VE, Oberti JC, Ríos-Luci C, León LG, Marler L, Li G, Pezzuto JM, van Breemen RB, Padrón JM, Hueso-Falcón I, Estévez-Braun A. García ME, et al. Among authors: hueso falcon i. Eur J Med Chem. 2014 Jul 23;82:68-81. doi: 10.1016/j.ejmech.2014.05.045. Epub 2014 May 20. Eur J Med Chem. 2014. PMID: 24878636
Synthesis and anti-inflammatory activity of ent-kaurene derivatives.
Hueso-Falcón I, Cuadrado I, Cidre F, Amaro-Luis JM, Ravelo AG, Estevez-Braun A, de Las Heras B, Hortelano S. Hueso-Falcón I, et al. Eur J Med Chem. 2011 Apr;46(4):1291-305. doi: 10.1016/j.ejmech.2011.01.052. Epub 2011 Feb 3. Eur J Med Chem. 2011. PMID: 21334121
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Among authors: hueso falcon i. Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425. Oncotarget. 2017. PMID: 27557509 Free PMC article.
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
Martín-Rodríguez P, Guerra B, Hueso-Falcón I, Aranda-Tavío H, Díaz-Chico J, Quintana J, Estévez F, Díaz-Chico B, Amesty A, Estévez-Braun A, Fernández-Pérez L. Martín-Rodríguez P, et al. Among authors: hueso falcon i. Front Pharmacol. 2019 Jan 9;9:1546. doi: 10.3389/fphar.2018.01546. eCollection 2018. Front Pharmacol. 2019. PMID: 30687103 Free PMC article.
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Among authors: hueso falcon i. Oncotarget. 2018 Aug 14;9(63):32272. doi: 10.18632/oncotarget.26008. eCollection 2018 Aug 14. Oncotarget. 2018. PMID: 30181817 Free PMC article.